Dr. Velasco-Velazquez is Professor in the School of Medicine, National Autonomous University of Mexico (UNAM). He received his PhD from UNAM in 2003 and has posdoctoral training at Thomas Jefferson University, Philadelphia PA, USA. Dr. Velasco-Velazquez is an expert in the development and preclinical evaluation of pharmochemical and biotech drugs. His current research focuses on the generation of new agents for targeting cancer stem cells. He has lectured +40 courses at the UNAAM, mainly on Pharmacology and Cancer Cell Biology. He is the Associate Editor of BioMed Research International, Technology in Cancer Research and Treatment, member of the editorial boards and a reviewer of several scientific journals, and has published more than 80 peer-reviewed articles.